Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease
Journal of Controlled Release · 2023-02 · 354 · 1-18
DOI: 10.1016/j.jconrel.2022.12.044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2023-02. Verfasst von Yuji Pu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China. Hauptthemen laut MEDLINE: Polymers, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 192 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
The inflammatory bowel disease (IBD) is incurable, chronic, recrudescent disorders in the inflamed intestines. Current clinic treatments are challenged by systemic exposure-induced severe side effects, inefficiency after long-term treatment, and increased risks of infection and malignancy due to immunosuppression. Fortunately, naturally bioactive small molecules, reactive oxygen species scavengers (or antioxidants), and gut microbiota modulators have emerged as promising candidates for the IBD treatment. Polymeric systems have been engineered as a delivery vehicle to improve the bioavailability and efficacy of these therapeutic agents through targeting the mucosa and enhancing intestinal adhesion and retention, and reduce their systemic toxicity. Herein we survey polymer-derived drug delivery systems for combating the IBD. Advanced delivery technologies, therapeutic intervention strategies, and the principles for the construction of hierarchical, mucosa-targeting, and bioresponsive systems are elaborated, providing insights into design and development of from-bench-to-bedside drug delivery polymeric systems for the IBD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.
- School of Preclinical Medicine, Chengdu University, Chengdu 610106, China.
- College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou 325027, China.
- Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital, Functional and Molecular Imaging Key Laboratory of Sichuan Province, Sichuan University, Chengdu 610041, China.
- National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China. Electronic address: bhe@scu.edu.cn.
Förderung
- Sichuan Province Science and Technology Support Program
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Pu, Y., Fan, X., Zhang, Z., Guo, Z., Pan, Q., Gao, W., Luo, K., & He, B. (2023). Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease. Journal of Controlled Release, 354, 1-18. https://doi.org/10.1016/j.jconrel.2022.12.044
Vancouver
Pu Y, Fan X, Zhang Z, Guo Z, Pan Q, Gao W, et al. Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease. Journal of Controlled Release. 2023;354:1-18. doi:10.1016/j.jconrel.2022.12.044
BibTeX
@article{Pu2023,
author = {Pu, Yuji and Fan, Xi and Zhang, Zhuangzhuang and Guo, Zhaoyuan and Pan, Qingqing and Gao, Wenxia and Luo, Kui and He, Bin},
title = {Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease},
journal = {Journal of Controlled Release},
year = {2023},
volume = {354},
pages = {1--18},
doi = {10.1016/j.jconrel.2022.12.044}
}
EUVIMED